Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

Ovarian Cancer Clinical Trial

Official title:

Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01544049
• Other study ID #: STUDY00000276
• Status: Completed
• Start date: December 2011
• Est. completion date: September 4, 2018

Study information

• Verified date: September 2018
• Source: University of Washington
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.

Description:

Women will be found eligible for this study after an eligibility questionnaire given over the phone. If one is found eligible, she will be sent a consent and paper survey to fill out and send back to the research coordinator. Once that is completed, she will be given a phone interview in order answer additional questions of interest. Lastly, the study participant will be contacted once a year over the phone to obtain follow-up information.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: September 4, 2018
• Est. primary completion date: September 4, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Female of at least 18 years of age

• Must speak English fluently

• Have had fallopian tubes removed as a method of ovarian cancer prevention

Exclusion Criteria:

• Males

• Females under the age of 18

Related Conditions & MeSH terms

• Neoplasms, Glandular and Epithelial
• Ovarian Cancer
• Ovarian Neoplasms

Locations

Country	Name	City	State
United States	University of Washington	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Describe subject experience in undergoing Salpingectomy as a means of riks reduction	Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure	At conclusion of study